ULVAC’s order recovery is real, but the earnings power is still being rebuilt

The print matters because it changes the burden of proof. ULVAC’s revenue came in at ¥67,738.0 million against the street’s ¥61,614.3 million estimate, a +9.9% surprise, while EPS of ¥59.22 missed the ¥113.70 estimate by -47.9%. That split is the whole story of the quarter: customers are ordering and tools are shipping, but the income statement is not yet translating volume into the level of earnings investors expected. The revenue result was not an isolated optical beat either. The company’s quarterly history shows revenue at ¥52,729.0 million in Q1 FY2025, ¥71,164.0 million in Q2 FY2025, and ¥67,738.0 million in Q3 FY2025, with the just-reported revenue QoQ versus 2026-03-31 listed at 0.0% and YoY versus four quarters ago at +6.7%. That is a stabilizing revenue base after the trough-like ¥52,729.0 million quarter, but the EPS miss says the mix, cost structure, and below-operating-line effects still matter more than the revenue beat alone.

The revenue trajectory is therefore better described as repaired rather than fully healed. ULVAC has seen the line swing materially over the last several reported quarters, from ¥73,853.0 million in Q2 FY2024 to ¥52,854.0 million in Q3 FY2024, then ¥63,458.0 million in Q4 FY2024, ¥52,729.0 million in Q1 FY2025, ¥71,164.0 million in Q2 FY2025, and ¥67,738.0 million in Q3 FY2025. The key positive is that the latest quarter avoided another downshift after the Q2 FY2025 rebound, and gross margin recovered to 32.0% from 29.1% in Q2 FY2025 and 29.7% in Q1 FY2025. That margin level also sits close to prior stronger quarters such as 32.2% in Q2 FY2024 and 33.3% in Q3 FY2024, even though the EPS outcome was weaker than the revenue beat would normally imply. The financial pattern supports the idea that demand is returning sooner than clean profitability.

The margin picture explains why the market should not treat the revenue beat as a clean all-clear. Gross margin at 32.0% is an improvement from 29.1%, but the call materials show cumulative pressure: “Gross Profit Margin 31.3% 32.2% 33.3% 32.2% 30.5% 31.8% 29.7% 29.1% 32.0% 30.3% -2.0pt.” The wording here matters less than the sequence embedded in the company’s own table: quarterly gross margin improved, while the cumulative margin remains lower. In the same call materials, SG&A moved through “13.4 14.5 15.4 43.3 +3.5 +9%,” and operating profit through “2.3 6.2 6.3 14.7 -6.0 -29%.” That is the reason the quarter feels uneven. ULVAC has revenue and gross margin stabilization, but the expense base and accumulated profit decline prevent the demand recovery from flowing cleanly to EPS.

The order book is the strongest part of the event, and it is also the part that makes the EPS miss more tolerable than it otherwise would be. Management’s prepared material stated, “Q3 orders received totaled ¥ 99.1 billion, with cumulative Q3 orders reaching ¥ 236.2 billion,” a formulation worth quoting because it anchors both the quarterly acceleration and the backlog-building context in the company’s own cadence. The surrounding order table is more forceful: “Orders Received 225.6 280.0 236.2 310.0 +84.4 +37% +30.0 +11%.” This is not a management team merely saying activity is improving; it is taking the order forecast upward to ¥310.0 billion from the prior forecast and showing a cumulative Q3 order base already at ¥236.2 billion. For semiconductor equipment, that is the difference between a revenue beat that may fade and a revenue beat with follow-through potential.

That follow-through, however, is not yet matched by the full-year profit guide. The company’s own forecast table shows “Net Sales 251.2 250.0 191.6 260.0 +8.8 +4% +10.0 +4%,” but also “Operating Profit 26.5 28.5 14.7 19.0 -7.5 -28% -9.5 -33%.” This is the most important internal contradiction in the update: orders and net sales are being revised in a direction that confirms demand, while operating profit is being revised down. The call excerpt attributes the reduction to one-time items, stating that operating profit was revised downward to ¥19.0 billion versus the previous forecast by -¥9.5 billion due to ¥5.8 billion in one-time factors. Even if investors are willing to normalize one-time impacts, the remaining issue is that operating profit margin in the company table moves from 10.6% to 7.7% and the latest forecast shows 7.3%. That is not a small conversion gap; it frames FY2025 as a year of order recovery with depressed earnings quality.

The longer-term targets are meant to reframe that conversion gap as temporary, but they also raise the execution bar. Management’s reform discussion says, “As a result, we target FY2031/6 net sales of ¥ 360.0 billion, operating profit of ¥ 79.0 billion,” and that quote earns its place because it is a direct strategic commitment rather than a descriptive quarterly statistic. The ambition is clear: management is not pitching ULVAC as a low-margin cyclical rebound alone, but as a company that can structurally expand profit dollars over the plan period. Still, this quarter forces investors to ask what must change between the current forecast path and that FY2031/6 aspiration. Orders are already strong, and net sales are already being guided to ¥260.0 billion, yet operating profit is being guided to ¥19.0 billion. The long-range plan only becomes investable if the company demonstrates that current cost friction, one-time charges, and mix pressure do not become permanent features of the recovery.

The delivery of the call reinforces that mixed message. The tone history shows sentiment falling from 0.52 in Q1 FY2026 to -0.09 in Q2 FY2026, with a call-over-call delta of -0.61. Guidance tone also slipped from 0.15 to 0.01, a delta of -0.14, while tone confidence moved from 0.67 to 0.62, a delta of -0.04. At the same time, ai_optimism jumped from 0.00 to 0.93 and uncertainty eased from 32.9 to 31.7, a delta of -1.2. That combination is unusual but understandable in this context: the transcript language is not broadly positive, because operating profit and EPS are under pressure, yet the forward-looking setup is materially better because orders are accelerating and the medium-term plan remains intact. The tone data, in other words, reads like the financials: confidence in demand, caution on earnings conversion.

The tone shift also matters because management had to balance good news on orders with bad news on profit in the same communication. In the prior tone series, Q4 FY2025 sentiment was 0.50 and Q1 FY2026 sentiment was 0.52, before the drop to -0.09 in Q2 FY2026. That swing should not be dismissed as a language-model artifact when it lines up with the guide mechanics. Guidance tone was 0.11 in Q4 FY2025, 0.15 in Q1 FY2026, and 0.01 in Q2 FY2026, while uncertainty was 28.8, 32.9, and 31.7 across those same calls. The company is still speaking with a forward order story, but it is no longer speaking from a clean profit-upgrade position. For a sell-side thesis, that distinction matters: the debate should move from “is demand recovering?” to “what multiple is appropriate for a recovery where operating leverage is delayed?”

The peer context supports the same interpretation. Within the wafer fab equipment peer set, ULVAC’s reported ¥67,738.0 million revenue is much smaller than TOELY at ¥724,894.9 million and 7751.T at ¥1,093,653.0 million, but its revenue YoY of +28.2% is the strongest number in the table. The problem is that ULVAC’s gross margin of 32.0% sits well below TOELY at 46.8%, 7751.T at 46.2%, 7735.T at 40.8%, 7731.T at 40.5%, and 6525.T at 39.4%, while only modestly above 6361.T at 31.6% and clearly above 6302.T at 25.0%. That comparison is not meant to force unlike-for-like conclusions across different equipment mixes, but it does frame the valuation debate. ULVAC currently offers above-peer growth in the latest quarter, but not premium gross-margin structure. Investors can pay for the growth signal, but they should demand proof that the margin bridge is real.

The supply-chain read-through is constructive but narrow. ULVAC is exposed to TSMC through equipment and high-purity sputtering targets, including Co, Ti, and W, and to Samsung through sputtering targets. For TSMC, the read-through is that vacuum process equipment and target-related demand remains consistent with a capex environment where advanced manufacturing and materials intensity support supplier orders. For Samsung, the read-through is more about sputtering target demand than a broad equipment-cycle conclusion. The absence of listed suppliers to ULVAC in the supplied chain data limits upstream inference, so the cleanest conclusion is downstream: ULVAC’s ¥99.1 billion Q3 orders and ¥310.0 billion order forecast are supportive signals for customers investing in process capacity, but they do not by themselves identify a bottleneck supplier beneficiary.

The dividend update adds one more clue about management’s priorities. The call material says the dividend forecast was revised to ¥152, versus the previous forecast by -¥12, while the initial payout ratio of 40.4% was maintained. That is not a growth-stock signal; it is a capital allocation decision tethered to lowered profit expectations. The company is protecting the payout framework, not trying to override the earnings downgrade with a larger shareholder-return message. In the context of a -47.9% EPS surprise against the street estimate, that is sensible. It also reinforces the idea that the quarter should not be bought simply because revenue beat by +9.9%. The equity case rests on whether today’s orders become higher-quality revenue, not whether management can cushion the near-term optics.

The investment conclusion is therefore positive on the cycle and guarded on the stock’s near-term earnings narrative. ULVAC has delivered a credible demand signal: revenue of ¥67,738.0 million exceeded expectations, gross margin recovered to 32.0%, Q3 orders reached ¥99.1 billion, cumulative Q3 orders reached ¥236.2 billion, and the order forecast moved to ¥310.0 billion. But the same event delivered EPS of ¥59.22 versus ¥113.70 expected, operating profit guidance of ¥19.0 billion, and operating profit margin guidance of 7.3%. That is not a contradiction to ignore; it is the central valuation question. The best reading is that ULVAC is entering the next phase of the equipment cycle with better visibility than earnings, and with a medium-term plan that is credible only if the next several quarters show operating leverage. Until then, this is a demand recovery story with a margin probation attached.